PCO-371

N/A

Report date: 2025/12/30 20:00:13
NME

Base Information

Drug NamePCO-371
Drug Alias NamePCO-371
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionParathyroid hormone receptor agonists
TargetsParathyroid hormone receptor
Therapy Area/IndicationsHypoparathyroidism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesHungary +[4
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesChugai Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsHypoparathyroidism

Other Information

ATC CodeN/A
Related LinksN/A